Phocas Financial Corp. Has $5.54 Million Stock Holdings in Integer Holdings Co. (NYSE:ITGR)

Phocas Financial Corp. trimmed its position in Integer Holdings Co. (NYSE:ITGR - Free Report) by 36.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 55,882 shares of the medical equipment provider's stock after selling 32,430 shares during the quarter. Phocas Financial Corp. owned about 0.17% of Integer worth $5,537,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also modified their holdings of the company. BlackRock Inc. increased its position in Integer by 0.6% during the first quarter. BlackRock Inc. now owns 6,018,773 shares of the medical equipment provider's stock worth $484,933,000 after acquiring an additional 38,664 shares during the period. Vanguard Group Inc. increased its position in Integer by 0.4% during the third quarter. Vanguard Group Inc. now owns 3,843,992 shares of the medical equipment provider's stock worth $301,484,000 after acquiring an additional 15,300 shares during the period. Victory Capital Management Inc. increased its position in Integer by 8.9% during the third quarter. Victory Capital Management Inc. now owns 1,632,549 shares of the medical equipment provider's stock worth $128,041,000 after acquiring an additional 133,898 shares during the period. State Street Corp increased its position in Integer by 1.6% during the second quarter. State Street Corp now owns 1,356,627 shares of the medical equipment provider's stock worth $120,211,000 after acquiring an additional 21,795 shares during the period. Finally, Macquarie Group Ltd. increased its position in Integer by 0.3% during the first quarter. Macquarie Group Ltd. now owns 972,726 shares of the medical equipment provider's stock worth $75,386,000 after acquiring an additional 3,361 shares during the period. 99.29% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities analysts recently issued reports on the stock. Benchmark boosted their target price on shares of Integer from $105.00 to $130.00 and gave the stock a "buy" rating in a research report on Thursday, March 28th. KeyCorp increased their price target on shares of Integer from $123.00 to $139.00 and gave the stock an "overweight" rating in a research report on Tuesday, April 9th. Finally, CL King initiated coverage on shares of Integer in a research report on Thursday, March 14th. They issued a "buy" rating and a $137.00 price target for the company. Three equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to MarketBeat, Integer presently has an average rating of "Moderate Buy" and a consensus price target of $117.60.

Integer Price Performance

NYSE:ITGR traded down $1.20 during mid-day trading on Friday, hitting $115.77. The company's stock had a trading volume of 222,043 shares, compared to its average volume of 298,935. Integer Holdings Co. has a fifty-two week low of $69.40 and a fifty-two week high of $119.00. The company has a current ratio of 2.80, a quick ratio of 1.71 and a debt-to-equity ratio of 0.64. The company has a market capitalization of $3.88 billion, a price-to-earnings ratio of 43.04, a P/E/G ratio of 1.46 and a beta of 1.10. The stock has a fifty day moving average of $110.49 and a 200-day moving average of $97.38.

Integer (NYSE:ITGR - Get Free Report) last posted its quarterly earnings data on Thursday, February 15th. The medical equipment provider reported $1.39 earnings per share for the quarter, topping the consensus estimate of $1.34 by $0.05. The company had revenue of $413.15 million during the quarter, compared to analyst estimates of $409.04 million. Integer had a net margin of 5.68% and a return on equity of 10.80%. The company's revenue was up 10.9% on a year-over-year basis. During the same quarter last year, the business posted $1.11 earnings per share. As a group, equities analysts forecast that Integer Holdings Co. will post 5.28 EPS for the current fiscal year.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.